Cerebrovascular Laboratory, Department of Neurosurgery, Columbia University , New York, NY , USA.
Front Neurol. 2013 Jun 10;4:69. doi: 10.3389/fneur.2013.00069. eCollection 2013.
Acute ischemic stroke is a devastating disease that is often complicated by hemorrhagic transformation. While significant advances have been made over the past two decades with regard to emergent treatment of AIS, many of the therapeutic options are limited by an increased risk of hemorrhage. Here, we sought to review the rates of hemorrhagic transformation in the major clinical trials of AIS intervention. Since the reviewed clinical trials vary significantly in terms of study design, eligibility criteria, stroke severity, and baseline demographic data, direct comparisons between the various trials is not valid. Nevertheless, this review is intended to consolidate the pertinent data on hemorrhagic transformation in order to call attention to any patterns that may warrant further investigation.
急性缺血性脑卒中是一种破坏性疾病,常伴有出血性转化。尽管在过去二十年中,针对急性缺血性脑卒中的紧急治疗已经取得了重大进展,但许多治疗选择都受到出血风险增加的限制。在这里,我们试图回顾急性缺血性脑卒中干预的主要临床试验中的出血性转化发生率。由于所回顾的临床试验在研究设计、入选标准、卒中严重程度和基线人口统计学数据方面存在显著差异,因此直接比较各个试验是无效的。然而,本综述旨在整合有关出血性转化的相关数据,以引起对任何可能需要进一步研究的模式的关注。